165 related articles for article (PubMed ID: 35409724)
1. Evaluation of BNT162b2 Vaccine Effectiveness in Galicia, Northwest Spain.
Pardo-Seco J; Mallah N; López-Pérez LR; González-Pérez JM; Rosón B; Otero-Barrós MT; Durán-Parrondo C; Rodríguez-Tenreiro C; Rivero-Calle I; Gómez-Carballa A; Salas A; Martinón-Torres F
Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409724
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain.
Mallah N; Pardo-Seco J; Ares-Gómez S; López-Pérez LR; González-Pérez JM; Rosón B; Otero-Barrós MT; Durán-Parrondo C; Nartallo-Penas V; Mirás-Carballal S; Rodríguez-Tenreiro-Sánchez C; Rivero-Calle I; Gómez-Carballa A; Salas A; Martinón-Torres F
Pediatr Allergy Immunol; 2023 Oct; 34(10):e14037. PubMed ID: 37877845
[TBL] [Abstract][Full Text] [Related]
3. Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
Fleming-Dutra KE; Britton A; Shang N; Derado G; Link-Gelles R; Accorsi EK; Smith ZR; Miller J; Verani JR; Schrag SJ
JAMA; 2022 Jun; 327(22):2210-2219. PubMed ID: 35560036
[TBL] [Abstract][Full Text] [Related]
4. Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study.
Suah JL; Husin M; Tok PSK; Tng BH; Thevananthan T; Low EV; Appannan MR; Muhamad Zin F; Mohd Zin S; Yahaya H; Peariasamy KM; Sivasampu S
Int J Infect Dis; 2022 Jun; 119():69-76. PubMed ID: 35331933
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain.
Mallah N; Pardo-Seco J; López-Pérez LR; González-Pérez JM; Rosón B; Otero-Barrós MT; Durán-Parrondo C; Nartallo-Penas V; Mirás-Carballal S; Rodríguez-Tenreiro C; Rivero-Calle I; Gómez-Carballa A; Salas A; Martinón-Torres F
Environ Res; 2022 Dec; 215(Pt 2):114252. PubMed ID: 36096168
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV.
Chambers C; Samji H; Cooper CL; Costiniuk CT; Janjua NZ; Kroch AE; Arbess G; Benoit AC; Buchan SA; Chung H; Kendall CE; Kwong JC; Langlois MA; Lee SM; Mbuagbaw L; McCullagh J; Moineddin R; Nambiar D; Walmsley S; Anis AH; Burchell AN;
AIDS; 2022 Dec; 36(15):F17-F26. PubMed ID: 36254892
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years.
Oliveira EA; Oliveira MCL; Silva ACSE; Colosimo EA; Mak RH; Vasconcelos MA; Silva LR; Martelli DB; Pinhati CC; Martelli-Júnior H
World J Pediatr; 2023 Oct; 19(10):949-960. PubMed ID: 36914907
[TBL] [Abstract][Full Text] [Related]
8. Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil.
Cerqueira-Silva T; Katikireddi SV; de Araujo Oliveira V; Flores-Ortiz R; Júnior JB; Paixão ES; Robertson C; Penna GO; Werneck GL; Barreto ML; Pearce N; Sheikh A; Barral-Netto M; Boaventura VS
Nat Med; 2022 Apr; 28(4):838-843. PubMed ID: 35140406
[TBL] [Abstract][Full Text] [Related]
9. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
Klein NP; Stockwell MS; Demarco M; Gaglani M; Kharbanda AB; Irving SA; Rao S; Grannis SJ; Dascomb K; Murthy K; Rowley EA; Dalton AF; DeSilva MB; Dixon BE; Natarajan K; Stenehjem E; Naleway AL; Lewis N; Ong TC; Patel P; Konatham D; Embi PJ; Reese SE; Han J; Grisel N; Goddard K; Barron MA; Dickerson M; Liao IC; Fadel WF; Yang DH; Arndorfer J; Fireman B; Griggs EP; Valvi NR; Hallowell C; Zerbo O; Reynolds S; Ferdinands J; Wondimu MH; Williams J; Bozio CH; Link-Gelles R; Azziz-Baumgartner E; Schrag SJ; Thompson MG; Verani JR
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):352-358. PubMed ID: 35239634
[TBL] [Abstract][Full Text] [Related]
11. Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia.
Husin M; Tok PSK; Suah JL; Thevananthan T; Tng BH; Peariasamy KM; Sivasampu S
Int J Infect Dis; 2022 Aug; 121():55-57. PubMed ID: 35500793
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study.
Wan EYF; Mok AHY; Yan VKC; Chan CIY; Wang B; Lai FTT; Chui CSL; Li X; Wong CKH; Lau CS; Wong ICK; Chan EWY
J Travel Med; 2022 Dec; 29(8):. PubMed ID: 36250571
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
Olson SM; Newhams MM; Halasa NB; Price AM; Boom JA; Sahni LC; Pannaraj PS; Irby K; Walker TC; Schwartz SP; Maddux AB; Mack EH; Bradford TT; Schuster JE; Nofziger RA; Cameron MA; Chiotos K; Cullimore ML; Gertz SJ; Levy ER; Kong M; Cvijanovich NZ; Staat MA; Kamidani S; Chatani BM; Bhumbra SS; Bline KE; Gaspers MG; Hobbs CV; Heidemann SM; Maamari M; Flori HR; Hume JR; Zinter MS; Michelson KN; Zambrano LD; Campbell AP; Patel MM; Randolph AG;
N Engl J Med; 2022 Feb; 386(8):713-723. PubMed ID: 35021004
[TBL] [Abstract][Full Text] [Related]
15. Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).
Katz MA; Harlev EB; Chazan B; Chowers M; Greenberg D; Peretz A; Tshori S; Levy J; Yacobi M; Hirsch A; Amichay D; Weinberger R; Dor AB; Taraday EK; Reznik D; Chayat CB; Sagas D; Zvi HB; Berdinstein R; Rashid G; Avni YS; Mandelboim M; Zuckerman N; Rainy N; Akriv A; Dagan N; Kepten E; Barda N; Balicer RD
Vaccine; 2022 Jan; 40(3):512-520. PubMed ID: 34903372
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans.
Dickerman BA; Gerlovin H; Madenci AL; Kurgansky KE; Ferolito BR; Figueroa Muñiz MJ; Gagnon DR; Gaziano JM; Cho K; Casas JP; Hernán MA
N Engl J Med; 2022 Jan; 386(2):105-115. PubMed ID: 34942066
[TBL] [Abstract][Full Text] [Related]
17. Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study.
Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Pályi B; Formanek-Balku E; Molnár GA; Herczeg R; Gyenesei A; Miseta A; Kollár L; Wittmann I; Müller C; Kásler M
Clin Microbiol Infect; 2022 Mar; 28(3):398-404. PubMed ID: 34838783
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Clinical Effectiveness of BNT162b2 COVID-19 Vaccine in US Adolescents.
Oliveira CR; Niccolai LM; Sheikha H; Elmansy L; Kalinich CC; Grubaugh ND; Shapiro ED;
JAMA Netw Open; 2022 Mar; 5(3):e220935. PubMed ID: 35238933
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccine effectiveness against hospitalization due to SARS-CoV-2: A test-negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain.
Mazagatos C; Delgado-Sanz C; Monge S; Pozo F; Oliva J; Sandonis V; Gandarillas A; Quiñones-Rubio C; Ruiz-Sopeña C; Gallardo-García V; Basile L; Barranco-Boada MI; Hidalgo-Pardo O; Vazquez-Cancela O; García-Vázquez M; Fernández-Sierra A; Milagro-Beamonte A; Ordobás M; Martínez-Ochoa E; Fernández-Arribas S; Lorusso N; Martínez A; García-Fulgueiras A; Sastre-Palou B; Losada-Castillo I; Martínez-Cuenca S; Rodríguez-Del Águila M; Latorre M; Larrauri A;
Influenza Other Respir Viruses; 2022 Nov; 16(6):1014-1025. PubMed ID: 35880469
[TBL] [Abstract][Full Text] [Related]
20. The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data.
Chodick G; Tene L; Rotem RS; Patalon T; Gazit S; Ben-Tov A; Weil C; Goldshtein I; Twig G; Cohen D; Muhsen K
Clin Infect Dis; 2022 Feb; 74(3):472-478. PubMed ID: 33999127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
